Form 4: Macrogenics Director Federica F. O'Brien Reports Stock Transactions
SEC Form 4 Filing
Director Federica F. O'Brien reports the vesting and disposal of 4,500 restricted stock units (RSUs) of Macrogenics Inc. (MGNX) on May 20, 2024.
Summary
- Federica F. O'Brien, a director of Macrogenics Inc. (MGNX), filed a Form 4 with the SEC.
- The report details the vesting of 4,500 Restricted Stock Units (RSUs) on May 20, 2024.
- These RSUs were granted on May 31, 2023, and each RSU represents the right to receive one share of Macrogenics Common Stock.
- The vesting date was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.
- The director disposed of 4,500 common stock shares on the same day.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard reporting of stock transactions by a company director.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it reflects the standard vesting and disposal of equity compensation.
Key Dates
| Date | Description |
|---|---|
| 05/31/2023 | The restricted stock unit (RSU) grant was approved by the Board of Directors. |
| 05/20/2024 | RSUs vested and shares disposed of. |
| 05/21/2024 | Issuer's 2024 Annual Meeting of Stockholders. |
| 05/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.